Cleviprex FDA Approval History
FDA Approved: Yes (First approved August 1, 2008)
Brand name: Cleviprex
Generic name: clevidipine butyrate
Dosage form: Injectable Emulsion
Company: The Medicines Company
Treatment for: High Blood Pressure
Cleviprex (clevidipine) is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.
Development timeline for Cleviprex
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.